4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-089158
General Counsel sold 13,514 shares at an average $101.42 ($1,370,647)
- General Counsel acquired 13,514 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murdock Hunter R. General Counsel | 2025-06-20 | Option exercise 10b5-1 | +7,500 | $29.91 | $224,325 | 7,500 | D |
| Murdock Hunter R. General Counsel | 2025-06-20 | Sale 10b5-1 | −7,500 | $102.47 | $768,525 | 0 | D |
| Murdock Hunter R. General Counsel | 2025-06-23 | Option exercise 10b5-1 | +6,014 | $29.91 | $179,879 | 6,014 | D |
| Murdock Hunter R. General Counsel | 2025-06-23 | Sale 10b5-1 | −6,014 | $100.12 | $602,122 | 0 | D |
| Derivatives | |||||||
| Murdock Hunter R. General Counsel | 2025-06-20 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 22,383 | D | ||
| Murdock Hunter R. General Counsel | 2025-06-23 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,014 | 16,369 | D | ||
| Open-market sales · 13,514 sh · avg $101.42 · $1,370,647 | |||||||
Loading xslF345X05/ownership.xml…